Share on StockTwits

CVS Caremark (NYSE:CVS) will post its Q114 quarterly earnings results on Friday, May 2nd. Analysts expect CVS Caremark to post earnings of $1.05 per share and revenue of $32.31 billion for the quarter. CVS Caremark has set its Q1 guidance at $1.03-1.06 EPS and its FY14 guidance at $4.36-4.50 EPS.

CVS Caremark (NYSE:CVS) last announced its earnings results on Tuesday, February 11th. The company reported $1.12 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.11 by $0.01. The company had revenue of $32.80 million for the quarter, compared to the consensus estimate of $32.67 million. During the same quarter in the prior year, the company posted $1.14 earnings per share. The company’s quarterly revenue was up 4.6% on a year-over-year basis. On average, analysts expect CVS Caremark to post $4.47 EPS for the current fiscal year and $5.02 EPS for the next fiscal year.

Shares of CVS Caremark (NYSE:CVS) opened at 72.72 on Thursday. CVS Caremark has a 52 week low of $55.66 and a 52 week high of $76.36. The stock’s 50-day moving average is $73.80 and its 200-day moving average is $68.97. The company has a market cap of $85.737 billion and a P/E ratio of 19.63.

A number of research firms have recently commented on CVS. Analysts at Susquehanna raised their price target on shares of CVS Caremark from $80.00 to $85.00 in a research note on Tuesday. They now have a “positive” rating on the stock. On a related note, analysts at FBR Capital Markets raised their price target on shares of CVS Caremark from $80.00 to $84.00 in a research note on Wednesday, April 9th. Finally, analysts at Argus raised their price target on shares of CVS Caremark from $77.00 to $83.00 in a research note on Friday, April 4th. They now have a “buy” rating on the stock. They noted that the move was a valuation call. Seven analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company. CVS Caremark has an average rating of “Buy” and a consensus target price of $75.25.

CVS Caremark Corporation (NYSE:CVS), together with its subsidiaries, is a pharmacy health care provider in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.